Advertisement

Press Release

ASHP Publishes New Edition of Popular Teddy Bear Book

8/8/2013

The American Society of Health-System Pharmacists (ASHP) has published the tenth edition of its popular Pediatric Injectable Drugs, widely known as the “Teddy Bear Book.”
 
Pediatric Injectable Drugs, Tenth Edition , edited by Stephanie J. Phelps, Pharm.D., BCPS; Tracy M. Hagemann, Pharm.D., FCCP, FPPAG; Kelley R. Lee, Pharm.D., BCPS; and A. Jill Thompson, Pharm.D., BCPS, is an invaluable resource for any pharmacist who works with children.
 
The Teddy Bear Book has provided reliable, evidence-based information specific to pediatric injectable drugs for more than two decades. With the publication of this new edition, the reference now covers 238 drugs commonly used in the treatment of infants and children, including 20 that are new to this edition. The reference covers neonates through adolescent children and includes age-specific dosing and administration guidelines. As with previous editions, the structure of each of the drug monographs covers the following areas:
 
  • Brand names,
  • Medication error potential,
  • Contraindications and warnings,
  • Infusion-related cautions,
  • Dosage (age specific),
  • Dosage adjustment in organ dysfunction,
  • Maximum dosage,
  • Additives,
  • Suitable diluents,
  • Maximum concentrations,
  • Preparation and delivery,
  • I.V. push,
  • Intermittent infusion,
  • Continuous infusion,
  • Other routes of administration, and
  • Comments.
Also included is a comprehensive list of abbreviations and more than 4,800 references. This is the only pediatric parenteral drug reference that covers limited fluid amounts, maximum doses, and limited intravenous sites—issues that pediatric practitioners often face with their patient population, from neonates through adolescents.
 
As a companion to the text, a mobile app is currently being developed for both single-user and institutional access. Visit www.ashp.org/teddybear for updates and additional material, information about the app, eBook, or to place an order (ISBN: 978-1-85828-379-8), or email custserv@ashp.org or call 866-279-0681 (U.S. & Canada), or 001-301-664-8700 (international). To arrange an interview, book signing, or to discuss co-marketing or bulk sales, please contact Rachel Gellman at rgellman@ashp.org.
 
About the Editors

Stephanie J. Phelps, Pharm.D., BCPS, FCCP, FAPhA, is currently a professor of clinical pharmacy and pediatrics at the University of Tennessee Health Science Center (UTHSC) and associate dean of academic affairs for the College of Pharmacy. For over a decade, she served as director of experiential education for the college. She currently serves as chair of the Pharmacy Academy of the National Academies of Practice. During her career, Phelps has participated in the education of five post-doctoral fellows and over 50 pediatric pharmacy residents. She is editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics and has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.
 
Tracy M. Hagemann, Pharm.D., FCCP, FPPAG, is an associate professor at the University of Oklahoma College of Pharmacy and an adjunct associate professor at the College of Medicine, Department of Pediatrics. Her focus of practice and research is in pediatric hematology and oncology. Her teaching and research has resulted in the publication of over 40 peer-reviewed journal articles and over 50 scientific abstracts. Dr. Hagemann has published book chapters in pediatric sickle cell disease in addition to her co-editorship of Pediatric Injectable Drugs. 
 
Kelley R. Lee, Pharm.D., BCPS, served as a clinical pharmacy specialist and then the clinical pharmacy manager at Le Bonheur Children’s Hospital and part-time professor of clinical pharmacy at the University of Tennessee Health Science Center. She has recently shifted focus to infectious diseases and is currently a clinical pharmacy specialist in Antimicrobial Stewardship at Le Bonheur Children’s Hospital. Lee’s practice and research interests have primarily been the appropriate use of medications in pediatric patients, particularly with the use of antibiotics. She has published numerous manuscripts, abstracts, and letters-to-the-editor on this subject.
 
A. Jill Thompson, Pharm.D., BCPS, is the coordinator of pediatric clinical pharmacy services and is a clinical specialist in pediatric critical care in the Department of Pharmacy Services, Medical University of South Carolina (MUSC), Charleston, South Carolina. She also serves as an adjunct assistant professor in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy, MUSC Campus. Thompson participates in clinical research regarding pediatric critical care and works closely with the pharmacy residency programs at MUSC. Prior to becoming a co-editor of Pediatric Injectable Drugs, she served as manuscript editor for the Journal of Pediatric Pharmacology and Therapeutics for seven years and is now a member of the editorial board.
 
About ASHP
 
ASHP is the national professional organization whose 40,000 members include pharmacists, pharmacy technicians, and pharmacy students who provide patient care services in hospitals, health systems, and ambulatory clinics. For 70 years, the Society has been on the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's website, www.ashp.org, or its consumer website, www.safemedication.com.
 
-END-

 

Contact Us
For questions, comments, or more information on this article, please contact Ellen Wilcox, Director, Public Relations via telephone at 301-664-8799 or via e-mail at publicinfo@ashp.org.
Advertisement